Cvi Holdings, LLC Regulus Therapeutics Inc. Transaction History

Cvi Holdings, LLC

  • $11.5 Million
  • Q2 2024

A detailed history of Cvi Holdings, LLC transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Cvi Holdings, LLC holds 401,012 shares of RGLS stock, worth $3.27 Million. This represents 6.25% of its overall portfolio holdings.

Number of Shares
401,012
Previous 1,406,250 71.48%
Holding current value
$3.27 Million
Previous $4.05 Million 82.3%
% of portfolio
6.25%
Previous 30.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$1.79 - $2.8 $1.8 Million - $2.81 Million
-1,005,238 Reduced 71.48%
401,012 $717,000
Q1 2024

May 07, 2024
BUY
$1.13 - $2.88 $1.59 Million - $4.05 Million
1,406,250 New
1,406,250 $4.05 Million

Others Institutions Holding RGLS

# of Institutions
4
Shares Held
4.52M
Call Options Held
0
Put Options Held
0
View Full List

About Regulus Therapeutics Inc.

RGLS Quotes by TradingView
  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $119M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email